Global Bipolar Disorder Therapeutics Market to 2026 - Featuring AbbVie, Astellas Pharma and Gedeon R
DUBLIN--(BUSINESS WIRE)--The "Bipolar Disorder Therapeutics - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.Amid the COVID-19 crisis, the global market for Bipolar Disorder Therapeutics estimated at US$5.6 Billion in the year 2020, is projected to reach a revised si...